Comparison of the 1- and 5-year effectiveness of adalimumab, etanercept and ustekinumab in patients with psoriasis in daily clinical practice: results from the prospective BioCAPTURE registry-Reference-Cited by-同舟云学术

Comparison of the 1- and 5-year effectiveness of adalimumab, etanercept and ustekinumab in patients with psoriasis in daily clinical practice: results from the prospective BioCAPTURE registry

Published:2017-03-10 Issue:4 Volume:176 Page:1001-1009
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Zweegers J.¹,Groenewoud J.M.M.²,van den Reek J.M.P.A.¹,Otero M.E.¹,van de Kerkhof P.C.M.¹,Driessen R.J.B.¹,van Lümig P.P.M.¹,Njoo M.D.³,Ossenkoppele P.M.³,Mommers J.M.⁴,Koetsier M.I.A.⁵,Arnold W.P.⁶,Andriessen M.P.M.⁷,Kuijpers A.L.A.⁸,Berends M.A.M.⁹,Kievit W.²,de Jong E.M.G.J.¹

Affiliation:

1. Department of Dermatology; Radboud University Medical Center; Nijmegen the Netherlands

2. Radboud University Medical Center; Radboud Institute for Health Sciences; Nijmegen the Netherlands

3. Department of Dermatology; Ziekenhuisgroep Twente; Almelo/Hengelo the Netherlands

4. Department of Dermatology; St Anna Ziekenhuis; Geldrop the Netherlands

5. Department of Dermatology; Gelre Ziekenhuizen; Apeldoorn the Netherlands

6. Department of Dermatology; Ziekenhuis Gelderse Vallei; Ede the Netherlands

7. Department of Dermatology; Jeroen Bosch Ziekenhuis; Den Bosch the Netherlands

8. Department of Dermatology; Maxima Medisch Centrum; Eindhoven/Veldhoven the Netherlands

9. Department of Dermatology; Slingeland Ziekenhuis; Doetinchem the Netherlands

Funder

University Medical Center St Radboud Foundation

Publisher

Wiley

Subject

Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjd.15023/fullpdf

Reference36 articles.

1. Psoriasis;Nestle;N Engl J Med,2009

2. Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis;Griffiths;N Engl J Med,2010

3. Etanercept as monotherapy in patients with psoriasis;Leonardi;N Engl J Med,2003

4. Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: double-blind, randomized controlled trial and open-label extension study;Gordon;J Am Acad Dermatol,2006

5. Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial;Chaudhari;Lancet,2001

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug survival analysis of etanercept compared with monoclonal antibody tumour necrosis factor-α inhibitors in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a propensity score-matched analysis from the Czech ATTRA registry;Scandinavian Journal of Rheumatology;2024-08-06

2. Dose escalation of biologic treatment in patients with moderate‐to‐severe psoriasis in Japan;Experimental Dermatology;2024-05

3. Effectiveness of biologic treatment for psoriasis in Malaysia: Real-world evidence and review of current evidence from Southeast Asia;Dermatologica Sinica;2024-04

4. Genetic Influence on Treatment Response in Psoriasis: New Insights into Personalized Medicine;International Journal of Molecular Sciences;2023-06-07

5. Direct Comparison of Real-world Effectiveness of Biologics for Psoriasis using Absolute and Relative Psoriasis Area and Severity Index Scores in a Prospective Multicentre Cohort;Acta Dermato-Venereologica;2022-05-16